Cargando…
Partial SAA patients benefit from delayed response of IST
INTRODUCTION: Severe aplastic anemia(SAA)is a severe disease characterized by immune-mediated bone marrow failure and pancytopenia. Immunosuppressive therapy (ATG plus CsA, IST) is the standard treatment for patients who are not suitable for allogeneic hematopoietic stem cell transplantation (allo-H...
Autores principales: | Wang, Ting, Wang, Chaomeng, Liu, Chunyan, Shao, Zonghong, Fu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951814/ https://www.ncbi.nlm.nih.gov/pubmed/36845107 http://dx.doi.org/10.3389/fimmu.2023.1067977 |
Ejemplares similares
-
Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1
por: Abouelasrar Salama, Sara, et al.
Publicado: (2020) -
PB1947: ELTROMBOPAG COMBINED WITH IST AS A MULTICENTER STUDY OF THE FIRST LINE TREATMENT OF CHILDREN WITH SAA.
por: Yang, L., et al.
Publicado: (2022) -
De novo Synthesis of SAA1 in the Placenta Participates in Parturition
por: Gan, Xiao-Wen, et al.
Publicado: (2020) -
P765: MIB2/SUZ12 REGULATED THE PROLIFERATION OF PNH CLONE
por: Zeng, Lijie, et al.
Publicado: (2023) -
The shortening telomere length of T lymphocytes maybe associated with hyper-function in servere aplastic anemia
por: Wang, Chaomeng, et al.
Publicado: (2018)